======= APLNR ======= == Gene Information == * **Official Symbol**: APLNR * **Official Name**: apelin receptor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=187|187]] * **UniProt**: [[https://www.uniprot.org/uniprot/P35414|P35414]] * **Interactions**: [[https://thebiogrid.org/search.php?search=APLNR&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20APLNR|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600052|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Receptor for apelin receptor early endogenous ligand (APELA) and apelin (APLN) hormones coupled to G proteins that inhibit adenylate cyclase activity (PubMed:11090199, PubMed:25639753, PubMed:28137936). Plays a key role in early development such as gastrulation, blood vessels formation and heart morphogenesis by acting as a receptor for APELA hormone (By similarity). May promote angioblast migration toward the embryonic midline, i.e. the position of the future vessel formation, during vasculogenesis (By similarity). Promotes sinus venosus (SV)- derived endothelial cells migration into the developing heart to promote coronary blood vessel development (By similarity). Plays also a role in various processes in adults such as regulation of blood vessel formation, blood pressure, heart contractility and heart failure (PubMed:25639753, PubMed:28137936). {ECO:0000250|UniProtKB:P79960, ECO:0000250|UniProtKB:Q7SZP9, ECO:0000250|UniProtKB:Q9WV08, ECO:0000269|PubMed:11090199, ECO:0000269|PubMed:25639753, ECO:0000269|PubMed:28137936}. |7tm 1| |positive regulation of inhibitory G protein-coupled receptor phosphorylation| |apelin receptor activity| |regulation of inhibitory G protein-coupled receptor phosphorylation| |apelin receptor signaling pathway| |positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis| |regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis| |adult heart development| |negative regulation of cAMP-mediated signaling| |positive regulation of sprouting angiogenesis| |positive regulation of release of sequestered calcium ion into cytosol| |coronary vasculature development| |regulation of cAMP-mediated signaling| |positive regulation of calcium ion transport into cytosol| |vasculogenesis| |regulation of sprouting angiogenesis| |positive regulation of calcium ion transmembrane transport| |regulation of release of sequestered calcium ion into cytosol| |positive regulation of endothelial cell proliferation| |regulation of calcium ion transport into cytosol| |positive regulation of calcium ion transport| |regulation of sequestering of calcium ion| |regulation of endothelial cell proliferation| |positive regulation of cation transmembrane transport| |regulation of G protein-coupled receptor signaling pathway| |regulation of calcium ion transmembrane transport| |positive regulation of ion transmembrane transport| |gastrulation| |positive regulation of angiogenesis| |positive regulation of vasculature development| |positive regulation of epithelial cell proliferation| |positive regulation of transmembrane transport| |signaling receptor activity| |regulation of calcium ion transport| |positive regulation of ion transport| |positive regulation of cytosolic calcium ion concentration| |regulation of angiogenesis| |angiogenesis| |regulation of vasculature development| |regulation of cytosolic calcium ion concentration| |regulation of epithelial cell proliferation| |regulation of cation transmembrane transport| |regulation of metal ion transport| |blood vessel morphogenesis| |cellular calcium ion homeostasis| |calcium ion homeostasis| |cellular divalent inorganic cation homeostasis| |regulation of ion transmembrane transport| |blood vessel development| |divalent inorganic cation homeostasis| |regulation of body fluid levels| |negative regulation of intracellular signal transduction| |vasculature development| |cardiovascular system development| |heart development| |cellular metal ion homeostasis| |regulation of transmembrane transport| |embryonic morphogenesis| |metal ion homeostasis| |cellular cation homeostasis| |cellular ion homeostasis| |tube morphogenesis| |regulation of ion transport| |cation homeostasis| |inorganic ion homeostasis| |G protein-coupled receptor activity| |cellular chemical homeostasis| |ion homeostasis| |tube development| |circulatory system development| |anatomical structure formation involved in morphogenesis| |cellular homeostasis| |regulation of cellular localization| |positive regulation of cell population proliferation| |embryo development| |positive regulation of transport| |positive regulation of protein phosphorylation| |positive regulation of phosphorylation| |regulation of anatomical structure morphogenesis| |chemical homeostasis| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |positive regulation of protein modification process| |negative regulation of signal transduction| |G protein-coupled receptor signaling pathway| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |integral component of plasma membrane| |regulation of protein phosphorylation| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |homeostatic process| |positive regulation of protein metabolic process| |positive regulation of multicellular organismal process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| |regulation of transport| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10578 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}